BVF Inc’s NGM Biopharmaceuticals NGM Stock Holding History
Bought
Maintained
Sold
Other funds holding NGM
PM
BVF Inc's NGM Position: Q2 2022 in Review
BVF Inc sold out of NGM Biopharmaceuticals (NGM) in Q2 2022, closing a stake of 955,000 shares — an estimated $14.6M sold.
BVF Inc first reported a position in NGM in Q2 2021 and held it in 4 quarters. The position peaked at $20.1M in Q3 2021. 123 funds tracked by Wall St. Rank hold NGM as of Q2 2022.
- BVF Inc reported no remaining NGM Biopharmaceuticals position as of Q2 2022 after selling out during the quarter.
- BVF Inc sold 955,000 NGM Biopharmaceuticals shares in Q2 2022, an estimated $14.6M.
- BVF Inc first reported a position in NGM Biopharmaceuticals in Q2 2021 and held it in 4 quarters.
- BVF Inc's NGM Biopharmaceuticals position peaked at $20.1M in Q3 2021.
- 123 funds tracked by Wall St. Rank held NGM Biopharmaceuticals as of Q2 2022.
Based on BVF Inc's 13F filing for Q2 2022, filed 15 Aug 2022.